Medical Community Stands Against The FDA On Avastin
The National Comprehensive Cancer Network is one of the most highly respected medical organizations in the country. Now, as government reports show that the number of people dying from all cancers has reached record lows, NCCN is squaring off with the federal government's Food and Drug Administration in a battle with thousands of women's lives in the balance. The FDA decided in December to ...

FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.1 The FDA has approved linagliptin as a monotherapy or in combination with other commonly prescribed medications for type 2 ...

FDA Requests Input On Development Of User Fee Program For Biosimilar And Interchangeable Biological Products
The U.S. Food and Drug Administration is requesting input from stakeholders and the public relating to the development of a user fee program for biosimilar and interchangeable biological product (351(k)) applications. Biological products are produced in a living system such as a microorganism, plant, or animal cell, while small molecule drugs are typically made through chemical synthesis...